BIOLASE Names New Vice Presidents of Marketing and Human Resources

Download as PDF

IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that it has appointed veteran medical device executives Michael Roux as its Vice President of Marketing and Matthew Wilson as its Vice President of Human Resources, effective immediately. Both are new members of the Company’s executive leadership team and will report to BIOLASE President and CEO Harold C. Flynn, Jr.

Michael Roux

Mr. Roux has significant leadership experience in marketing and product management and comes to BIOLASE with a wide range of medical device and multinational business expertise with leading publicly-owned companies. Most recently, Mr. Roux served for three years as Vice President of Product Management with Patient Safety Technologies, which was acquired by Stryker in 2014. Prior to that, Mr. Roux spent four years as Global Product Director for the Respiratory Care franchise of Hill-Rom, and 19 years at 3M Company where he held positions of increasing responsibility within product engineering, six-sigma, global product marketing leadership and business development groups.

Mr. Roux holds a Bachelor of Science Degree in Industrial Engineering from the University of Minnesota, and a Masters of Business Administration in Marketing from the University of St. Thomas.

Matthew Wilson

Mr. Wilson brings over 15 years of experience in Human Resources Management in diverse industries, including dental medical device, commercial real estate and aerospace. Most recently, Mr. Wilson served for nearly eight years as Human Resources Director for the Zimmer Biomet, Inc. (previously Zimmer, Inc.) dental business. Prior to that role, Mr. Wilson spent over three years at CBRE Group, Inc. as Human Resources Director and Senior Organization Development Consultant. Mr. Wilson began his career in Human Resources in Raytheon Company's two-year Human Resources Leadership Development Program, followed by an additional three years as Principal Human Resources Generalist for the company's Integrated Airborne Systems organization.

Mr. Wilson holds a Masters of Business Administration in International Management from Thunderbird School of Global Management and a Bachelor of Arts in Marketing from the University of Utah.

BIOLASE President and CEO, Harold C. Flynn, Jr. stated, “I am very pleased and quite proud to be able to expand the BIOLASE executive leadership team with Michael and Matt, two highly talented and experienced professionals.

“Michael has led strategic and downstream tactical marketing, development, clinical education, clinical research, and sales training for some of the most renowned companies in the medical device and consumer goods sectors. His experience in customer-centric marketing, his technical acumen, and analytic prowess through his six-sigma black belt certification make him well suited to help lead our product realization and commercial efforts to significantly higher levels.”

Flynn continued, “I had the good fortune of working with Matt for over six years as my Human Resources leader and business partner at Zimmer Dental, so he is a well-known entity to me. Matt is a remarkable judge of talent, and has great experience in the recruitment, retention, and development of professionals across all disciplines, with special emphasis on the Sales function where he led the human resources efforts on a sales force with well over 150 territories. He has been certified in multiple world-class organizational and development programs which will greatly benefit BIOLASE and its employees.

“Through their individual contributions and leadership, I expect Michael and Matt will raise our level of play significantly, and along with the rest of the leadership team, they will be integral to achieving BIOLASE’s vision of being a thriving company within a high performance culture that changed the standard of care in dentistry.”

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x-rays and CAD/CAM scanners. BIOLASE’s products are focused on technologies that advance the practice of dentistry to both the dentist and their patients. The Company's proprietary laser products incorporate approximately 250 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 31,200 laser systems to date in over 90 countries around the world. Laser products under development address the Company’s core dental market and other adjacent medical and consumer markets.

For updates and information on WaterLase® iPlus™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements contained in this press release that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE's strategic initiatives and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations regarding future benefits of cost-saving measures and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described, from time-to-time, in the “Risk Factors” section of BIOLASE's annual and quarterly reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained in this press release.

DresnerAllenCaron
Rene Caron (Investors)
949-474-4300
rene@allencaron.com
or
Len Hall (Media)
949-474-4300
len@allencaron.com

Source: BIOLASE, Inc.

Released May 4, 2016